Cold-Pressed Safflower Oil (Carthamus tinctorius)

Cold-pressed safflower oil (Carthamus tinctorius) is rich in conjugated linoleic acid (CLA) and high-oleic linoleic acid, which modulate adiponectin signaling and PPAR-gamma activation to improve body composition and metabolic markers. Clinical trials demonstrate measurable reductions in waist circumference, fasting blood glucose, and blood pressure in individuals with metabolic syndrome.

Origin & History

Cold-pressed safflower oil is derived from the seeds of Carthamus tinctorius L., an annual plant in the Asteraceae family native to Asia, Africa, and parts of Europe. The oil is extracted via cold-pressing, a mechanical method that applies pressure without heat or chemicals to preserve natural composition, resulting in higher vitamin E content and oxidative stability compared to solvent-extracted oils.

Historical & Cultural Context

Safflower (Carthamus tinctorius) has been used for centuries in traditional Chinese medicine systems, particularly the Wei safflower variant, for vitality and circulation support. Modern clinical interest stems from its high polyunsaturated fat content, specifically linoleic acid, for managing cholesterol and blood sugar levels.

Health Benefits

• Reduces waist circumference and blood pressure in metabolic syndrome patients (Strong evidence: RCT, n=67, -2.42 cm waist reduction, p<0.001)
• Improves blood sugar control and insulin sensitivity (Strong evidence: RCT, -5.03 mg/dL fasting glucose vs. +2.94 mg/dL placebo, p=0.003)
• Increases beneficial adiponectin levels after 12+ weeks of use (Moderate evidence: Two RCTs showing consistent increases)
• Reduces inflammation markers including CRP after 16 weeks (Moderate evidence: RCT in diabetic women)
• Raises HDL cholesterol levels in postmenopausal diabetic women (Moderate evidence: +0.12 mmol/L after 12 weeks)

How It Works

Cold-pressed safflower oil exerts metabolic effects primarily through its linoleic acid and CLA content, which activate peroxisome proliferator-activated receptor gamma (PPAR-γ), promoting adipocyte differentiation and upregulating adiponectin secretion. Elevated adiponectin enhances AMPK phosphorylation in skeletal muscle and liver, increasing glucose uptake via GLUT4 translocation and suppressing hepatic gluconeogenesis through inhibition of PEPCK and G6Pase enzymes. The oleic acid fraction additionally modulates endothelial nitric oxide synthase (eNOS) activity, contributing to vasodilation and observed reductions in blood pressure.

Scientific Research

Two key randomized controlled trials tested 8 g/day safflower oil: one in 67 metabolic syndrome patients for 12 weeks (PMID: 34487844) showing significant improvements in waist circumference, blood pressure, and glycemic control; another in 35 postmenopausal diabetic women for 16 weeks (PMID: 21616113) demonstrating increased adiponectin, reduced inflammation, and improved HDL cholesterol. No meta-analyses were identified in the research.

Clinical Summary

A randomized controlled trial (n=67) in metabolic syndrome patients found that cold-pressed safflower oil supplementation produced a statistically significant reduction in waist circumference of 2.42 cm (p<0.001) compared to placebo. The same trial reported a net difference of 7.97 mg/dL in fasting blood glucose between the safflower oil group (-5.03 mg/dL) and placebo group (+2.94 mg/dL), with a p-value of 0.003, indicating strong glycemic benefit. Evidence for blood pressure reduction and improvements in insulin sensitivity also derives from RCT data, lending a relatively strong evidence base for a dietary oil intervention. However, most trials are short-term and involve specific metabolic syndrome populations, so generalizability to healthy individuals remains limited.

Nutritional Profile

Cold-pressed safflower oil is composed almost entirely of fat (≈100 g fat per 100 g oil, ≈884 kcal/100 g), with negligible protein and zero carbohydrates or fiber. Fatty acid composition varies by cultivar type: high-linoleic variety (most common) contains ≈74–78% linoleic acid (omega-6, C18:2), ≈13–15% oleic acid (omega-9, C18:1), ≈5–8% palmitic acid (saturated, C16:0), and ≈2–3% stearic acid (saturated, C18:0). High-oleic variety contains ≈70–80% oleic acid and only ≈12–18% linoleic acid. Omega-3 (alpha-linolenic acid) content is negligible (<0.5%). Micronutrients: Vitamin E is the dominant micronutrient at ≈34–40 mg/100 g total tocopherols, predominantly as alpha-tocopherol (≈28–34 mg/100 g), with minor gamma-tocopherol (≈1–3 mg/100 g); cold-pressing preserves significantly more tocopherols than refined oils. Vitamin K1 (phylloquinone): ≈7–10 µg/100 g. Phytosterols: ≈440–500 mg/100 g, primarily beta-sitosterol (≈280–320 mg/100 g), campesterol (≈80–100 mg/100 g), and stigmasterol (≈20–30 mg/100 g); phytosterols compete with dietary cholesterol for intestinal absorption, contributing to LDL-lowering effects. Polyphenols: cold-pressed oil retains minor phenolic compounds including serotonin derivatives (N-feruloylserotonin and N-(p-coumaroyl)serotonin) at ≈50–150 mg/kg, which are largely absent in refined oils and are proposed contributors to anti-inflammatory and adiponectin-modulating effects. Carotenoids: trace amounts (≈0.1–0.5 mg/100 g), contributing to the pale yellow color. Bioavailability notes: Linoleic acid from safflower oil is highly bioavailable (>90% absorption); tocopherols from cold-pressed oils show enhanced bioavailability compared to synthetic forms; phytosterols require adequate fat intake to be absorbed but exert cholesterol-lowering effects at the intestinal lumen level rather than through systemic absorption.

Preparation & Dosage

Clinically studied dose: 8 g/day of cold-pressed safflower oil taken orally in divided doses for 12-16 weeks. No standardized extracts or powder forms have been studied in human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Omega-3 fatty acids, Vitamin E, Alpha-lipoic acid, Chromium, Cinnamon extract

Safety & Interactions

Cold-pressed safflower oil is generally well tolerated at dietary supplementation doses (typically 8–10 g/day), with mild gastrointestinal discomfort reported in a minority of participants in clinical trials. Individuals with known allergies to Asteraceae/Compositae plants (e.g., ragweed, chrysanthemum) should exercise caution due to potential cross-reactivity with Carthamus tinctorius. Safflower oil may potentiate the effects of anticoagulant medications such as warfarin by inhibiting platelet aggregation, warranting INR monitoring in those on blood thinners. Safety data in pregnancy and lactation are insufficient; use should be limited to food amounts, and high-dose supplementation is not recommended without medical supervision.